Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr 29:9:311.
doi: 10.12688/f1000research.23468.2. eCollection 2020.

Assessment of a demonstrator repository for individual clinical trial data built upon DSpace

Affiliations

Assessment of a demonstrator repository for individual clinical trial data built upon DSpace

Birol Tilki et al. F1000Res. .

Abstract

Background: Given the increasing number and heterogeneity of data repositories, an improvement and harmonisation of practice within repositories for clinical trial data is urgently needed. The objective of the study was to develop and evaluate a demonstrator repository, using a widely used repository system (DSpace), and then explore its suitability for providing access to individual participant data (IPD) from clinical research. Methods: After a study of the available options, DSpace (version 6.3) was selected as the software for developing a demonstrator implementation of a repository for clinical trial data. In total, 19 quality criteria were defined, using previous work assessing clinical data repositories as a guide, and the demonstrator implementation was then assessed with respect to those criteria. Results: Generally, the performance of the DSpace demonstrator repository in supporting sensitive personal data such as that from clinical trials was strong, with 14 requirements demonstrated (74%), including the necessary support for metadata and identifiers. Two requirements could not be demonstrated (the ability to include de-identification tools and the availabiltiy of a self-attestation system) and three requirements were only partially demonstrated (ability to provide links to de-identification tools and requirements, incorporation of a data transfer agreement in system workflow, and capability to offer managed access through application on a case by case basis). Conclusions: Technically, the system was able to support most of the pre-defined requirements, though there are areas where support could be improved. Of course, in a productive repository, appropriate policies and procedures would be needed to direct the use of the available technical features. A technical evaluation should therefore be seen as indicating a system's potential, rather than being a definite assessment of its suitability. DSpace clearly has considerable potential in this context and appears a suitable base for further exploration of the issues around storing sensitive data.

Keywords: DSpace; Repository; clinical trial; data sharing; individual participant data.

PubMed Disclaimer

Conflict of interest statement

No competing interests were disclosed.

References

    1. Ohmann C, Banzi R, Canham S, et al. : Sharing and reuse of individual participant data from clinical trials: principles and recommendations. BMJ Open. 2017;7(12):e018647. 10.1136/bmjopen-2017-018647 - DOI - PMC - PubMed
    1. Banzi R, Canham S, Kuchinke W, et al. : Evaluation of repositories for sharing individual-participant data from clinical studies. Trials. 2019;20(1):169. 10.1186/s13063-019-3253-3 - DOI - PMC - PubMed
    1. Austin CC, Brown S, Fong N, et al. : Research data repositories: Review of current features, gap analysis, and recommendations for minimum requirements. IASSIST Quarterly.Winter2015;39(4):24 10.29173/iq904 - DOI
    1. OECD Global Science Forum: Business models for sustainable research data repositories. OECD Science Technology and Industry Policy Paper No. 47,2017. Reference Source
    1. Ohmann C, Canham S, Banzi R, et al. : Classification of processes involved in sharing individual participant data from clinical trials [version 2; peer review: 3 approved]. F1000Res. 2018;7:138. 10.12688/f1000research.13789.2 - DOI - PMC - PubMed

Publication types